CALT
Calliditas Therapeutics AB American Depositary Shares
CALT
CALT
Delisted
CALT was delisted on the 20th of September, 2024.
21 hedge funds and large institutions have $21.8M invested in Calliditas Therapeutics AB American Depositary Shares in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Holders
21
Holding in Top 10
–
Calls
$662K
Puts
$1.1M
Top Buyers
| 1 | +$243K | |
| 2 | +$38.6K | |
| 3 | +$25.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$23.5K |
| 5 |
JPMorgan Chase & Co
New York
|
+$10.9K |
Top Sellers
| 1 | -$1.03M | |
| 2 | -$217K | |
| 3 | -$106K | |
| 4 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
-$32.3K |
| 5 |
Morgan Stanley
New York
|
-$28.9K |